AbbVie Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
9,895
8,374
8,407
6,423
9,789
8,061
Total Accounts Receivable
4,803
4,291
4,730
4,758
7,188
5,872
Inventories
1,150
1,124
1,719
1,444
1,605
1,605
Other Current Assets
2,000
2,299
1,458
3,562
2,641
1,407
Total Current Assets
17,848
16,088
16,314
16,187
21,223
16,945
Net Property, Plant & Equipment
2,298
2,485
2,565
2,604
2,803
2,883
Total Investments and Advances
118
92
145
1,783
2,090
1,420
Intangible Assets
8,167
7,375
32,877
44,313
43,344
36,896
Other Assets
767
1,507
1,149
1,212
1,326
1,208
Total Assets
29,198
27,547
53,050
66,099
70,786
59,352
ST Debt & Current Portion LT Debt
431
4,446
2,431
402
6,415
Accounts Payable
933
881
1,597
1,407
1,474
Other Current Liabilities
5,515
6,073
6,866
7,972
8,752
Total Current Liabilities
6,879
11,400
10,894
9,781
16,641
Long-Term Debt
14,292
10,565
29,240
36,440
30,953
Provision for Risks & Charges
1,628
2,220
1,949
2,085
2,740
Deferred Taxes
817
1,051
6,178
8,056
5,173
Other Liabilities
1,090
569
844
5,101
10,182
Total Liabilities
24,706
25,805
49,105
61,463
65,689
Common Equity (Total)
4,492
1,742
3,945
4,636
5,097
Total Shareholders' Equity
4,492
1,742
3,945
4,636
5,097
Total Equity
4,492
1,742
3,945
4,636
5,097
Liabilities & Shareholders' Equity
29,198
27,547
53,050
66,099
70,786

About AbbVie

View Profile
Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.